Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000389963> ?p ?o ?g. }
- W2000389963 endingPage "1153" @default.
- W2000389963 startingPage "1153" @default.
- W2000389963 abstract "Social anxiety disorder is a debilitating, highly prevalent disorder in children and adolescents. If left untreated, it can interfere with emotional, social, and school functioning.To evaluate the efficacy and tolerability of paroxetine in children and adolescents with social anxiety disorder.Multicenter, 16-week, randomized, double-blind, placebo-controlled, flexible-dose, parallel-group, outpatient study. Patients A total of 322 children (8-11 years of age) and adolescents (12-17 years of age) with social anxiety disorder as their predominant psychiatric illness. Intervention Eligible patients were randomized (1:1) to receive paroxetine (10-50 mg/d) or placebo.Four hundred twenty-five patients were screened, and 322 were randomized to treatment. Of these, 319 were included in the intention-to-treat population (paroxetine, n = 163; placebo, n = 156). At the week 16 last observation carried forward end point, the odds of responding (Clinical Global Impression-Improvement score of 1 or 2) were statistically significantly greater for paroxetine (77.6% response [125/161]) than for placebo (38.3% response [59/154]) (adjusted odds ratio, 7.02; 95% confidence interval, 4.07 to 12.11; P<.001). The proportion of patients who were very much improved (Clinical Global Impression-Improvement score of 1) was 47.8% (77/161) for paroxetine compared with 14.9% (23/154) for placebo. Adverse events occurring at an incidence of 5% or greater for paroxetine and twice that for placebo were insomnia (14.1% vs 5.8%), decreased appetite (8.0% vs 3.2%), and vomiting (6.7% vs 1.9%). Withdrawals due to adverse events were infrequent (5.5% [9/163] for paroxetine and 1.3% [2/156] for placebo).Paroxetine is an effective, generally well-tolerated treatment for pediatric social anxiety disorder." @default.
- W2000389963 created "2016-06-24" @default.
- W2000389963 creator A5016357209 @default.
- W2000389963 creator A5016394918 @default.
- W2000389963 creator A5025485984 @default.
- W2000389963 creator A5032346628 @default.
- W2000389963 creator A5036076257 @default.
- W2000389963 creator A5039778102 @default.
- W2000389963 creator A5048523667 @default.
- W2000389963 creator A5074969156 @default.
- W2000389963 creator A5075569712 @default.
- W2000389963 date "2004-11-01" @default.
- W2000389963 modified "2023-09-30" @default.
- W2000389963 title "A Multicenter, Randomized, Double-blind, Placebo-Controlled Trial ofParoxetine in Children and Adolescents With Social Anxiety Disorder" @default.
- W2000389963 cites W1718169872 @default.
- W2000389963 cites W1967557107 @default.
- W2000389963 cites W1968161022 @default.
- W2000389963 cites W1971990000 @default.
- W2000389963 cites W1987998341 @default.
- W2000389963 cites W1991162101 @default.
- W2000389963 cites W1994095895 @default.
- W2000389963 cites W1994543033 @default.
- W2000389963 cites W1996775535 @default.
- W2000389963 cites W2005618530 @default.
- W2000389963 cites W2012954533 @default.
- W2000389963 cites W2016866934 @default.
- W2000389963 cites W2018654578 @default.
- W2000389963 cites W2036634094 @default.
- W2000389963 cites W2046662203 @default.
- W2000389963 cites W2067023397 @default.
- W2000389963 cites W2071246021 @default.
- W2000389963 cites W2074573480 @default.
- W2000389963 cites W2083414722 @default.
- W2000389963 cites W2083756460 @default.
- W2000389963 cites W2084745983 @default.
- W2000389963 cites W2085622918 @default.
- W2000389963 cites W2092074358 @default.
- W2000389963 cites W2111373769 @default.
- W2000389963 cites W2111564971 @default.
- W2000389963 cites W2114734893 @default.
- W2000389963 cites W2158310359 @default.
- W2000389963 cites W2164855913 @default.
- W2000389963 cites W2330595721 @default.
- W2000389963 cites W3090293687 @default.
- W2000389963 cites W33568228 @default.
- W2000389963 cites W93044161 @default.
- W2000389963 doi "https://doi.org/10.1001/archpsyc.61.11.1153" @default.
- W2000389963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15520363" @default.
- W2000389963 hasPublicationYear "2004" @default.
- W2000389963 type Work @default.
- W2000389963 sameAs 2000389963 @default.
- W2000389963 citedByCount "216" @default.
- W2000389963 countsByYear W20003899632012 @default.
- W2000389963 countsByYear W20003899632013 @default.
- W2000389963 countsByYear W20003899632014 @default.
- W2000389963 countsByYear W20003899632015 @default.
- W2000389963 countsByYear W20003899632016 @default.
- W2000389963 countsByYear W20003899632017 @default.
- W2000389963 countsByYear W20003899632018 @default.
- W2000389963 countsByYear W20003899632019 @default.
- W2000389963 countsByYear W20003899632020 @default.
- W2000389963 countsByYear W20003899632021 @default.
- W2000389963 countsByYear W20003899632022 @default.
- W2000389963 countsByYear W20003899632023 @default.
- W2000389963 crossrefType "journal-article" @default.
- W2000389963 hasAuthorship W2000389963A5016357209 @default.
- W2000389963 hasAuthorship W2000389963A5016394918 @default.
- W2000389963 hasAuthorship W2000389963A5025485984 @default.
- W2000389963 hasAuthorship W2000389963A5032346628 @default.
- W2000389963 hasAuthorship W2000389963A5036076257 @default.
- W2000389963 hasAuthorship W2000389963A5039778102 @default.
- W2000389963 hasAuthorship W2000389963A5048523667 @default.
- W2000389963 hasAuthorship W2000389963A5074969156 @default.
- W2000389963 hasAuthorship W2000389963A5075569712 @default.
- W2000389963 hasConcept C118552586 @default.
- W2000389963 hasConcept C126322002 @default.
- W2000389963 hasConcept C142724271 @default.
- W2000389963 hasConcept C156957248 @default.
- W2000389963 hasConcept C15744967 @default.
- W2000389963 hasConcept C168563851 @default.
- W2000389963 hasConcept C197934379 @default.
- W2000389963 hasConcept C204787440 @default.
- W2000389963 hasConcept C27081682 @default.
- W2000389963 hasConcept C2776000289 @default.
- W2000389963 hasConcept C2776317618 @default.
- W2000389963 hasConcept C2777545354 @default.
- W2000389963 hasConcept C2777828372 @default.
- W2000389963 hasConcept C2778375690 @default.
- W2000389963 hasConcept C2779177272 @default.
- W2000389963 hasConcept C2908647359 @default.
- W2000389963 hasConcept C558461103 @default.
- W2000389963 hasConcept C71924100 @default.
- W2000389963 hasConcept C99454951 @default.
- W2000389963 hasConceptScore W2000389963C118552586 @default.
- W2000389963 hasConceptScore W2000389963C126322002 @default.
- W2000389963 hasConceptScore W2000389963C142724271 @default.
- W2000389963 hasConceptScore W2000389963C156957248 @default.
- W2000389963 hasConceptScore W2000389963C15744967 @default.